Investment Column: Await deal clearance before buying Cairn

Xaar; Severfield-Rowen


Our view: Hold

Share price: 428p (+8.3p)

The stock market fell on Tuesday, but Cairn Energy rallied to second place on the FTSE 100 index as investors bought in after the oil prospector issued what by all accounts were pleasing full-year results.

The update showed that the group moved to a pre-tax profit of $577m (£352m) last year, against a small loss in 2009. Cairn also reported progress in Greenland, where it is conducting a widely watched exploration campaign. The group said the offshore-Greenland programme has "the potential for transformational growth" and, given its track record, there is every reason to believe in its optimism.

Despite all this, we suspect that the share-price rise was mostly down to comments from chief executive Sir Bill Gammell, who said: "Cairn continues to believe the necessary approvals to complete the Vedanta transaction will be received and is working with the government of India in a positive and constructive manner".

The Vedanta transaction refers to Cairn's deal to sell control of its Indian arm, Cairn India, to the mining group Vedanta Resources. The transaction requires clearance from the Indian government, which has yet to make up its mind. Every week brings forth new reports of possible cabinet meetings or ad hoc statements from officials, but the issue has not been resolved. Even David Cameron has weighed in, mentioning the deal in a letter to his Indian counterpart, Dr Manmohan Singh.

That Cairn expects the deal to go through is of course a good thing. Earlier this month, the company said it hoped to conclude the divestment by the middle of next month. We are in no position to judge whether this deadline will be met, as it hinges on the actions of the Indian authorities.

What is clear – and this was highlighted by RBS analyst Phil Corbett – is that both companies appear committed to the deal, and would be unlikely to hesitate if a small extension were required.

The results showed that Cairn is a strong business. The Greenland campaign offers the potential for substantial upside gains. But although we were cheered by Cairn's confidence, we would not add to our holding until we have further clarity from the Indian government on the Vedanta deal.

Xaar

Our view: Buy

Share price: 234p (unchanged)

Xaar may sound like a baddie from Star Trek but it is actually in the business of making industrial ink-jet printheads. It suffered a tough credit crunch, but last night's results showed that it had regained its composure and booked healthy profits for 2010.

The boost followed strong demand for its industrial ink-jet kit, with the company saying that orders for certain products were so high that it could not keep up with demand. To meet the rush of orders for its so-called Platform 3 products, which are particularly beloved by the ceramics industry, the group raised £14m in a placing to expand its Huntingdon facility.

The shares are currently valued at a heavy multiple of 26 times forward earnings, but that falls to 17.6 times on the estimates for the following year. Given the forthcoming increase in capacity at Huntingdon, we think there is scope for gains.

Severfield-Rowen

Our view: Hold

Share price: 251p (+19p)

There was much to be gloomy about in Severfield-Rowen's final numbers, yet the fact its shares closed ahead last night shows the extent to which investors were prepared for the bad news by the structural steelwork supplier's profit warning in January.

At the time, it blamed delays to large office-building projects, a drop in public spending and the increased cost of steel, and yesterday's comments from the group made clear that 2011 will continue to be tough.

However, it is not just its involvement in the 2012 Olympics – its structural steel has been used for the main stadium – that means it is looking forward to next year.

There is optimism over its Indian joint venture, as well as commercial activity in the UK. It also used the economic downturn to double its market share, so if you hold the stock and are happy waiting, there certainly appears to be light at the end of the tunnel, despite the reduction of the dividend.

That said, given the pessimism regarding the coming months, if you are itching to get involved it may be better to wait for further weakness in the share price before wading in.

Suggested Topics
Start your day with The Independent, sign up for daily news emails
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Sales Assistant / Buyer

£15000 - £17000 per annum: Recruitment Genius: This company offers a range of ...

Recruitment Genius: Customer Service Advisor

£15000 - £16000 per annum: Recruitment Genius: Customer Service Advisors are r...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: SThree were established in 1986....

Recruitment Genius: Compliance Manager

£40000 - £60000 per annum: Recruitment Genius: A Compliance Manager is require...

Day In a Page

Greece debt crisis: What happened to democracy when it’s a case of 'Vote Yes or else'?

'The economic collapse has happened. What is at risk now is democracy...'

If it doesn’t work in Europe, how is it supposed to work in India or the Middle East, asks Robert Fisk
The science of swearing: What lies behind the use of four-letter words?

The science of swearing

What lies behind the use of four-letter words?
The Real Stories of Migrant Britain: Clive fled from Zimbabwe - now it won't have him back

The Real Stories of Migrant Britain

Clive fled from Zimbabwe - now it won’t have him back
Africa on the menu: Three foodie friends want to popularise dishes from the continent

Africa on the menu

Three foodie friends want to popularise dishes from the hot new continent
Donna Karan is stepping down after 30 years - so who will fill the DKNY creator's boots?

Who will fill Donna Karan's boots?

The designer is stepping down as Chief Designer of DKNY after 30 years. Alexander Fury looks back at the career of 'America's Chanel'
10 best statement lightbulbs

10 best statement lightbulbs

Dare to bare with some out-of-the-ordinary illumination
Wimbledon 2015: Heather Watson - 'I had Serena's poster on my wall – now I'm playing her'

Heather Watson: 'I had Serena's poster on my wall – now I'm playing her'

Briton pumped up for dream meeting with world No 1
Wimbledon 2015: Nick Bollettieri - It's time for big John Isner to produce the goods to go with his thumping serve

Nick Bollettieri's Wimbledon Files

It's time for big John Isner to produce the goods to go with his thumping serve
Dustin Brown: Who is the tennis player who knocked Rafael Nadal out of Wimbeldon 2015?

Dustin Brown

Who is the German player that knocked Nadal out of Wimbeldon 2015?
Ashes 2015: Damien Martyn - 'England are fired up again, just like in 2005...'

Damien Martyn: 'England are fired up again, just like in 2005...'

Australian veteran of that Ashes series, believes the hosts' may become unstoppable if they win the first Test
Tour de France 2015: Twins Simon and Adam Yates have a mountain to climb during Tour of duty

Twins have a mountain to climb during Tour of duty

Yates brothers will target the steepest sections in bid to win a stage in France
John Palmer: 'Goldfinger' of British crime was murdered, say police

Murder of the Brink’s-MAT mastermind

'Goldfinger' of British crime's life ended in a blaze of bullets, say police
Forget little green men - aliens will look like humans, says Cambridge University evolution expert

Forget little green men

Leading evolutionary biologist says aliens will look like humans
The Real Stories of Migrant Britain: An Algerian scientist adjusts to life working in a kebab shop

The Real Stories of Migrant Britain

An Algerian scientist struggles to adjust to her new life working in a Scottish kebab shop
Bodyworlds museum: Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy

Dying dream of Doctor Death

Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy